Cargando…

Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes

INTRODUCTION: Diabetic nephropathy is associated with specific histological changes. Early detection of poor glomerular and tubular function can be achieved with biomarkers of diabetes. The aim of this study was to evaluate the accuracy of kidney dysfunction biomarkers in type 2 diabetes (T2D). METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacci, Marcelo R., Chehter, Ethel Z., Azzalis, Ligia A., Costa de Aguiar Alves, Beatriz, Fonseca, Fernando L.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678634/
https://www.ncbi.nlm.nih.gov/pubmed/29142952
http://dx.doi.org/10.1016/j.ekir.2016.10.001
_version_ 1783277478277545984
author Bacci, Marcelo R.
Chehter, Ethel Z.
Azzalis, Ligia A.
Costa de Aguiar Alves, Beatriz
Fonseca, Fernando L.A.
author_facet Bacci, Marcelo R.
Chehter, Ethel Z.
Azzalis, Ligia A.
Costa de Aguiar Alves, Beatriz
Fonseca, Fernando L.A.
author_sort Bacci, Marcelo R.
collection PubMed
description INTRODUCTION: Diabetic nephropathy is associated with specific histological changes. Early detection of poor glomerular and tubular function can be achieved with biomarkers of diabetes. The aim of this study was to evaluate the accuracy of kidney dysfunction biomarkers in type 2 diabetes (T2D). METHODS: Patients with T2D were grouped according to their glycated hemoglobin level. Patients’ urine and blood samples were taken to measure cystatin C (CysC), neutrophil gelatinase-associated lipocalin, beta-trace protein levels, and the first morning void albumin-to-creatinine ratio. Patients in the end stage of renal disease or receiving dialysis were not included. Receiver operating characteristic curves were generated, and the areas under the curve were compared with the performance of the biomarkers used to evaluate kidney dysfunction in T2D. RESULTS: Ninety patients with T2D were chosen. CysC was positively correlated with creatinine (P < 0.001), estimated glomerular filtration rate (P < 0.001), and urinary beta-trace protein (P = 0.01). The area under the curve was 0.635 for CysC, 0.621 for serum neutrophil gelatinase-associated lipocalin, and 0.660 for the albumin-to-creatinine ratio. A crude logistic regression model showed a positive association between serum CysC (P = 0.01) and serum neutrophil gelatinase-associated lipocalin (P < 0.001). A linear regression model showed a positive association between serum CysC, creatinine, and estimated glomerular filtration rate (P < 0.001) but did not show a positive association with glycated hemoglobin (P = 0.892). DISCUSSION: Neutrophil gelatinase-associated lipocalin and serum CysC were positively associated with the presence of renal dysfunction and had better performance on receiver operating characteristic analysis than the other markers evaluated in patients with T2D without kidney dysfunction.
format Online
Article
Text
id pubmed-5678634
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56786342017-11-15 Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes Bacci, Marcelo R. Chehter, Ethel Z. Azzalis, Ligia A. Costa de Aguiar Alves, Beatriz Fonseca, Fernando L.A. Kidney Int Rep Clinical Research INTRODUCTION: Diabetic nephropathy is associated with specific histological changes. Early detection of poor glomerular and tubular function can be achieved with biomarkers of diabetes. The aim of this study was to evaluate the accuracy of kidney dysfunction biomarkers in type 2 diabetes (T2D). METHODS: Patients with T2D were grouped according to their glycated hemoglobin level. Patients’ urine and blood samples were taken to measure cystatin C (CysC), neutrophil gelatinase-associated lipocalin, beta-trace protein levels, and the first morning void albumin-to-creatinine ratio. Patients in the end stage of renal disease or receiving dialysis were not included. Receiver operating characteristic curves were generated, and the areas under the curve were compared with the performance of the biomarkers used to evaluate kidney dysfunction in T2D. RESULTS: Ninety patients with T2D were chosen. CysC was positively correlated with creatinine (P < 0.001), estimated glomerular filtration rate (P < 0.001), and urinary beta-trace protein (P = 0.01). The area under the curve was 0.635 for CysC, 0.621 for serum neutrophil gelatinase-associated lipocalin, and 0.660 for the albumin-to-creatinine ratio. A crude logistic regression model showed a positive association between serum CysC (P = 0.01) and serum neutrophil gelatinase-associated lipocalin (P < 0.001). A linear regression model showed a positive association between serum CysC, creatinine, and estimated glomerular filtration rate (P < 0.001) but did not show a positive association with glycated hemoglobin (P = 0.892). DISCUSSION: Neutrophil gelatinase-associated lipocalin and serum CysC were positively associated with the presence of renal dysfunction and had better performance on receiver operating characteristic analysis than the other markers evaluated in patients with T2D without kidney dysfunction. Elsevier 2016-10-15 /pmc/articles/PMC5678634/ /pubmed/29142952 http://dx.doi.org/10.1016/j.ekir.2016.10.001 Text en © 2016 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Bacci, Marcelo R.
Chehter, Ethel Z.
Azzalis, Ligia A.
Costa de Aguiar Alves, Beatriz
Fonseca, Fernando L.A.
Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
title Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
title_full Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
title_fullStr Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
title_full_unstemmed Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
title_short Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
title_sort serum ngal and cystatin c comparison with urinary albumin-to-creatinine ratio and inflammatory biomarkers as early predictors of renal dysfunction in patients with type 2 diabetes
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678634/
https://www.ncbi.nlm.nih.gov/pubmed/29142952
http://dx.doi.org/10.1016/j.ekir.2016.10.001
work_keys_str_mv AT baccimarcelor serumngalandcystatinccomparisonwithurinaryalbumintocreatinineratioandinflammatorybiomarkersasearlypredictorsofrenaldysfunctioninpatientswithtype2diabetes
AT chehterethelz serumngalandcystatinccomparisonwithurinaryalbumintocreatinineratioandinflammatorybiomarkersasearlypredictorsofrenaldysfunctioninpatientswithtype2diabetes
AT azzalisligiaa serumngalandcystatinccomparisonwithurinaryalbumintocreatinineratioandinflammatorybiomarkersasearlypredictorsofrenaldysfunctioninpatientswithtype2diabetes
AT costadeaguiaralvesbeatriz serumngalandcystatinccomparisonwithurinaryalbumintocreatinineratioandinflammatorybiomarkersasearlypredictorsofrenaldysfunctioninpatientswithtype2diabetes
AT fonsecafernandola serumngalandcystatinccomparisonwithurinaryalbumintocreatinineratioandinflammatorybiomarkersasearlypredictorsofrenaldysfunctioninpatientswithtype2diabetes